Company profile

PharmaEngine

4162 · TPEx (Taiwan oncology drug developer listed on the Taipei Exchange since 2002 under code 4162. [resolved 2026-08-05 by resolve-null-is-public; source: https://finance.yahoo.com/quote/4162.TWO/]) · Taiwan

Public Market Listing

4162TPEx

TPEx primary exchange listing

Live quotes, historical charts, and market capitalization for PharmaEngine are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(1 total)

1Total Assets

0Approved

0Phase 3 / Filed

1Phase 1–2 / Early

1Diseases

Showing 1 of 1 assets

		Target & Modality
PEP07	Phase 1	CHK1 (Checkpoint kinase 1)	Acute Myeloid Leukemia

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.